StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
40
This year
1
Publishing Date
2024 - 03 - 11
1
2023 - 11 - 08
1
2023 - 11 - 03
1
2023 - 09 - 26
1
2023 - 08 - 21
1
2023 - 08 - 03
1
2023 - 07 - 28
1
2023 - 06 - 20
1
2023 - 05 - 02
1
2023 - 04 - 28
1
2023 - 04 - 21
1
2023 - 03 - 02
1
2023 - 02 - 28
1
2022 - 12 - 21
1
2022 - 11 - 14
1
2022 - 11 - 09
1
2022 - 11 - 08
1
2022 - 11 - 04
1
2022 - 08 - 02
1
2022 - 07 - 29
1
2022 - 06 - 29
1
2022 - 05 - 05
1
2022 - 04 - 29
1
2022 - 02 - 28
1
2022 - 02 - 26
1
2021 - 11 - 03
2
2021 - 10 - 28
1
2021 - 08 - 23
1
2021 - 07 - 30
1
2021 - 07 - 28
1
2021 - 05 - 06
1
2021 - 04 - 29
1
2021 - 03 - 10
1
2021 - 03 - 04
1
2020 - 11 - 17
1
2020 - 10 - 29
1
2020 - 10 - 27
1
2020 - 07 - 30
1
2020 - 07 - 23
1
Sector
Health technology
40
Tags
Als
4
America
1
Annual needham
1
Annual needham virtual healthcare conference
1
Application
4
Approval
2
Association
2
Benefits
1
Biopharma
2
Bioscience
1
Biotech
1
Business
5
Cardio
3
Cardiology
5
Cardiovascular
6
Care
2
Clinical-trials-phase-ii
3
Conference
31
Diabetes
11
Diabetic
7
Disease
4
Drug
5
Duchenne
2
Earnings
4
Express
2
Fda
5
Financial
12
Financial results
11
Global
4
Health
2
Heart
24
Impact
3
Inpefa
6
J.p. morgan healthcare conference
3
Kidney
5
Lone-star-bio
13
Lx9211
12
Management
2
Market
3
Meeting
6
N/a
113
Offering
7
Pharmaceuticals
27
Phase 2
6
Positive
2
Potential
2
Presentation
3
Regulatory
2
Report
2
Results
40
Risk
4
Scripts
2
Sessions
3
Study
7
Thc
2
Therapeutics
3
Topline
3
Treatment
9
Trial
8
Update
8
Entities
Abbvie inc.
80
Agnico eagle mines limited
39
Alnylam pharmaceuticals, inc.
79
Amgen inc.
53
Apollo global management, inc
41
Arrival
183
B2gold corp
37
Baidu, inc.
39
Bank of montreal
37
Barrick gold corporation
48
Beigene, ltd.
50
Biontech se
53
Bnp paribas
73
Bristol-myers squibb company
64
Brookfield asset management inc
52
Coherus biosciences, inc.
45
Cvr partners, lp
42
Cytokinetics, incorporated
42
Dirtt environmental solutions ltd.
38
Eli lilly and company
203
First bank
88
Fortress biotech, inc.
60
Gilead sciences, inc.
51
Incyte corporation
72
Ionis pharmaceuticals, inc.
43
Jd.com, inc.
40
Jinkosolar holding company limited
39
Johnson & johnson
220
Kering
77
Lexicon pharmaceuticals, inc.
40
Ligand pharmaceuticals incorporated
46
Lithium corp
60
Marathon petroleum corporation
53
Medies
39
Mediwound ltd.
49
Morgan stanley
207
Mplx lp
53
Netease, inc.
57
Nextera energy partners, lp
44
Nextera energy, inc.
45
Novartis ag
52
Orange
331
Paid inc
168
Pfizer, inc.
62
Progressive corporation (the)
38
Provention bio, inc.
41
Regeneron pharmaceuticals, inc.
85
Sanofi
367
Seagen inc.
38
Sempra energy
40
Signature bank
39
T2 biosystems, inc.
43
Takeda pharmaceutical company limited
58
Teekay corporation
48
Teekay tankers ltd.
47
Teva pharmaceutical industries ltd
48
X financial
94
Xencor, inc.
39
Yamana gold inc.
39
Youdao, inc.
46
Symbols
LXRX
40
SNY
1
Exchanges
Nasdaq
40
Crawled Date
2024 - 03 - 11
1
2023 - 11 - 08
1
2023 - 11 - 03
1
2023 - 09 - 26
1
2023 - 08 - 21
1
2023 - 08 - 03
1
2023 - 07 - 28
1
2023 - 06 - 20
1
2023 - 05 - 02
1
2023 - 04 - 28
1
2023 - 04 - 21
1
2023 - 03 - 02
1
2023 - 02 - 28
1
2022 - 12 - 22
1
2022 - 11 - 14
1
2022 - 11 - 09
1
2022 - 11 - 08
1
2022 - 11 - 04
1
2022 - 09 - 02
1
2022 - 07 - 29
1
2022 - 06 - 29
1
2022 - 05 - 05
1
2022 - 04 - 29
1
2022 - 02 - 28
1
2022 - 02 - 26
1
2021 - 11 - 04
1
2021 - 11 - 03
1
2021 - 10 - 29
1
2021 - 08 - 23
1
2021 - 07 - 30
1
2021 - 07 - 28
1
2021 - 05 - 06
1
2021 - 04 - 29
1
2021 - 03 - 10
1
2021 - 03 - 05
1
2020 - 12 - 22
5
Crawled Time
00:00
2
00:11
1
01:00
1
04:20
1
09:00
1
11:00
3
12:00
4
12:20
1
13:00
4
13:20
1
14:00
2
18:48
5
20:00
4
21:00
3
22:00
4
22:12
1
23:00
2
Source
www.biospace.com
9
www.globenewswire.com
31
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Results
entities :
Lexicon pharmaceuticals, inc.
save search
Lexicon Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Provides Business Update
Published:
2024-03-11
(Crawled : 11:00)
- globenewswire.com
LXRX
|
$1.6
-0.62%
-0.63%
1.8M
|
Health Technology
|
-25.81%
|
O:
6.91%
H:
21.55%
C:
21.12%
business
update
pharmaceuticals
results
Lexicon Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update
Published:
2023-11-08
(Crawled : 12:00)
- globenewswire.com
LXRX
|
$1.6
-0.62%
-0.63%
1.8M
|
Health Technology
|
28.8%
|
O:
-10.4%
H:
10.71%
C:
1.79%
business
update
pharmaceuticals
financial
results
Lexicon Pharmaceuticals to Host Third Quarter 2023 Financial Results Conference Call and Webcast on November 8, 2023
Published:
2023-11-03
(Crawled : 13:00)
- globenewswire.com
LXRX
|
$1.6
-0.62%
-0.63%
1.8M
|
Health Technology
|
15.0%
|
O:
-1.43%
H:
8.7%
C:
7.25%
conference
pharmaceuticals
financial
results
Lexicon to Present Study Results Relating to Sotagliflozin and LX9211 at the 59th Annual Meeting of the European Association for the Study of Diabetes (EASD)
Published:
2023-09-26
(Crawled : 13:00)
- globenewswire.com
LXRX
|
$1.6
-0.62%
-0.63%
1.8M
|
Health Technology
|
51.89%
|
O:
-0.94%
H:
14.05%
C:
11.43%
lx9211
association
meeting
diabetes
results
study
Lexicon to Present Analyses of INPEFA™ (sotagliflozin) Clinical Study Results and Changing Patterns of Heart Failure Diagnoses at the European Society of Cardiology (ESC) Congress 2023
Published:
2023-08-21
(Crawled : 13:00)
- globenewswire.com
LXRX
|
$1.6
-0.62%
-0.63%
1.8M
|
Health Technology
|
-3.01%
|
O:
0.0%
H:
7.23%
C:
4.82%
heart
cardiology
results
study
Lexicon Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update
Published:
2023-08-03
(Crawled : 20:00)
- globenewswire.com
LXRX
|
$1.6
-0.62%
-0.63%
1.8M
|
Health Technology
|
-16.15%
|
O:
-6.25%
H:
3.89%
C:
3.89%
business
update
pharmaceuticals
financial
results
Lexicon Pharmaceuticals to Host Second Quarter 2023 Financial Results Conference Call and Webcast on August 3, 2023
Published:
2023-07-28
(Crawled : 20:00)
- globenewswire.com
LXRX
|
$1.6
-0.62%
-0.63%
1.8M
|
Health Technology
|
Email alert
Add to watchlist
conference
pharmaceuticals
financial
results
Lexicon to Present Study Results Relating to LX9211 and INPEFA™ (Sotagliflozin) at the American Diabetes Association’s 83rd Scientific Sessions
Published:
2023-06-20
(Crawled : 12:00)
- globenewswire.com
LXRX
|
$1.6
-0.62%
-0.63%
1.8M
|
Health Technology
|
-33.47%
|
O:
-0.41%
H:
0.0%
C:
-2.07%
lx9211
sessions
diabetes
results
study
Lexicon Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Business Update
Published:
2023-05-02
(Crawled : 20:00)
- globenewswire.com
LXRX
|
$1.6
-0.62%
-0.63%
1.8M
|
Health Technology
|
-32.35%
|
O:
4.62%
H:
11.64%
C:
10.04%
business
update
pharmaceuticals
financial
results
Lexicon Pharmaceuticals to Host First Quarter 2023 Financial Results Conference Call and Webcast on May 2, 2023
Published:
2023-04-28
(Crawled : 21:00)
- biospace.com/
LXRX
|
$1.6
-0.62%
-0.63%
1.8M
|
Health Technology
|
-31.78%
|
O:
0.85%
H:
3.57%
C:
0.42%
conference
pharmaceuticals
financial
results
Lexicon To Present Results From LX9211 Phase 2 Trial In Postherpetic Neuralgia At The 2023 American Academy Of Neurology (AAN) Annual Meeting And The British Pain Society (BPS) 56th Annual Scientific Meeting 2023
Published:
2023-04-21
(Crawled : 13:20)
- globenewswire.com
LXRX
|
$1.6
-0.62%
-0.63%
1.8M
|
Health Technology
|
-34.29%
|
O:
2.04%
H:
2.4%
C:
-0.4%
lx9211
meeting
trial
results
Lexicon Pharmaceuticals Reports Fourth Quarter 2022 Financial Results and Provides Business Update
Published:
2023-03-02
(Crawled : 21:00)
- globenewswire.com
LXRX
|
$1.6
-0.62%
-0.63%
1.8M
|
Health Technology
|
-26.15%
|
O:
0.92%
H:
29.55%
C:
21.82%
pharmaceuticals
financial
update
results
Lexicon Pharmaceuticals to Host Fourth Quarter 2022 Financial Results Conference Call and Webcast on March 2, 2023
Published:
2023-02-28
(Crawled : 22:00)
- globenewswire.com
LXRX
|
$1.6
-0.62%
-0.63%
1.8M
|
Health Technology
|
-28.44%
|
O:
0.44%
H:
1.77%
C:
-2.65%
pharmaceuticals
conference
financial
results
Lexicon Announces Topline Results From Phase 2 Proof-of-Concept Study of LX9211 in Postherpetic Neuralgia
Published:
2022-12-21
(Crawled : 00:00)
- biospace.com/
LXRX
|
$1.6
-0.62%
-0.63%
1.8M
|
Health Technology
|
-16.15%
|
O:
0.52%
H:
3.63%
C:
-1.55%
lx9211
topline
results
study
phase 2
Lexicon’s LX9211 Shows Significant and Consistent Benefits in the Treatment of Painful Diabetic Neuropathy in Full Results From the Phase 2 RELIEF-DPN-1 Trial Presented at the 16th Annual Pain Therapeutics Summit
Published:
2022-11-14
(Crawled : 22:00)
- globenewswire.com
LXRX
|
$1.6
-0.62%
-0.63%
1.8M
|
Health Technology
|
-30.9%
|
O:
3.43%
H:
2.07%
C:
-3.73%
lx9211
treatment
trial
therapeutics
results
benefits
diabetic
Lexicon Pharmaceuticals Reports Third Quarter 2022 Financial Results And Provides Business Update
Published:
2022-11-09
(Crawled : 23:00)
- biospace.com/
LXRX
|
$1.6
-0.62%
-0.63%
1.8M
|
Health Technology
|
-21.84%
|
O:
-0.97%
H:
0.49%
C:
-3.92%
pharmaceuticals
financial
update
results
Lexicon Pharmaceuticals Highlights Oral Presentation of Final Results From the RELIEF-DPN-1 Trial of LX9211 at the 16th Annual Pain Therapeutics Summit
Published:
2022-11-08
(Crawled : 14:00)
- globenewswire.com
LXRX
|
$1.6
-0.62%
-0.63%
1.8M
|
Health Technology
|
-24.41%
|
O:
0.94%
H:
0.47%
C:
-4.19%
lx9211
pharmaceuticals
trial
therapeutics
presentation
results
Lexicon Pharmaceuticals to Host Third Quarter 2022 Financial Results Conference Call and Webcast on November 9, 2022
Published:
2022-11-04
(Crawled : 13:00)
- globenewswire.com
LXRX
|
$1.6
-0.62%
-0.63%
1.8M
|
Health Technology
|
-24.77%
|
O:
0.47%
H:
0.47%
C:
-3.26%
pharmaceuticals
conference
financial
results
Lexicon Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update
Published:
2022-08-02
(Crawled : 09:00)
- globenewswire.com
LXRX
|
$1.6
-0.62%
-0.63%
1.8M
|
Health Technology
|
-38.08%
|
O:
0.38%
H:
6.51%
C:
3.07%
update
results
Lexicon Pharmaceuticals to Host Second Quarter 2022 Financial Results Conference Call and Webcast on August 2, 2022
Published:
2022-07-29
(Crawled : 12:20)
- globenewswire.com
LXRX
|
$1.6
-0.62%
-0.63%
1.8M
|
Health Technology
|
-32.92%
|
O:
1.67%
H:
0.0%
C:
-2.46%
conference
results
← Previous
1
2
Next →
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.